Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000665892 | SCV001250557 | pathogenic | Phenylketonuria | 2019-10-18 | reviewed by expert panel | curation | This c.441+3G>C (IVS4+3G>C) variant was documented at least 7 times in patients with PAH deficiency with a pathogenic or likely pathogenic variant in trans (PMID: 28982351, 5894915, 30050108). This variant was also documented in two patients homozygous for the c.441+3G>C variant, one diagnosed with mild PKU and one diagnosed with classic PKU (PMID: 30050108). This variant was documented 12 times in patients with PAH deficiency; DHPR activity, biopterin and/or pteridine analysis was performed to rule out other causes of hyperphenylalaninemia (PMID: 26503515, 16256386, 23932990). This variant is absent from the population databases ExAC and gnomAD. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_very strong, PM2, PP4_moderate. |
Counsyl | RCV000665892 | SCV000790088 | likely pathogenic | Phenylketonuria | 2017-03-15 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000665892 | SCV004201959 | pathogenic | Phenylketonuria | 2022-11-15 | criteria provided, single submitter | clinical testing | |
De |
RCV000088920 | SCV000119518 | not provided | not provided | no assertion provided | not provided |